Green Cross Health Ltd

As of March 31, 2026, Green Cross Health Ltd carries a market capitalization of 172.46M, placing it among publicly traded companies globally. Its enterprise value stands at 283.52M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Green Cross Health Ltd has 143.72M shares outstanding.

As of March 31, 2026, Green Cross Health Ltd trades at a trailing price-to-earnings ratio of 8.45. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 0.98.

As of March 31, 2026, Green Cross Health Ltd trades at an EV/EBITDA multiple of 4.56 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.52 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.81 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 283.52M versus a market cap of 172.46M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Green Cross Health Ltd maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 65.42, indicating elevated leverage, while an interest coverage ratio of 39.07 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Green Cross Health Ltd posted a return on equity (ROE) of 11.90, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.49 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.24, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.08, useful for judging operating efficiency across full business cycles. Inventory turnover of 6.94 indicates how many times Green Cross Health Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Green Cross Health Ltd recorded 9.92M in income tax expense. That works out to an effective tax rate of 27.70, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 35.82M, leaving 20.40M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Green Cross Health Ltd's stock has gained approximately 96.94% over the past 52 weeks. The 50-day moving average sits at 1.96, while the 200-day moving average is 1.65.

Over the twelve months ended March 31, 2026, Green Cross Health Ltd generated 544.50M in revenue and converted that into 20.40M in net income, yielding earnings per share of 0.18. EBITDA reached 62.20M, while operating income came in at 41.64M.

As of March 31, 2026, Green Cross Health Ltd holds 28.40M in cash and equivalents against 124.84M in total debt, resulting in a net debt position of -8.58M. Total book value stands at 176.21M, with working capital of -1.98M providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Green Cross Health Ltd posted a gross margin of 56.82, reflecting its pricing power and cost economics. The operating margin of 7.65 and net profit margin of 3.75 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Green Cross Health Ltd paid dividends of 0.09 per share. The dividend payout ratio of 41.02 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 23.84, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Green Cross Health Ltd shareholders.

Green Cross Health Ltd's most recent stock split took place on August 31, 2009 with a 100:101 split ratio.

As of March 31, 2026, Green Cross Health Ltd has an Altman Z-Score of 4.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.